Advisors Capital Management, LLC Eli Lilly & CO Transaction History

Advisors Capital Management, LLC

$6.15 Billion
Q3 2024

A detailed history of Advisors Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisors Capital Management, LLC holds 5,139 shares of LLY stock, worth $3.94 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,139

Previous 5,968 13.89%

Holding current value

$3.94 Million

Previous $5.4 Million 15.75%

% of portfolio

0.07%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $640,104 - $795,856	-829 Reduced 13.89%	5,139 $4.55 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $943,780 - $1.18 Million	-1,302 Reduced 17.91%	5,968 $5.4 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $794,732 - $1.06 Million	1,342 Added 22.64%	7,270 $5.66 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $323,517 - $381,384	616 Added 11.6%	5,928 $3.46 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $102,154 - $140,835	235 Added 4.63%	5,312 $2.85 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $129,072 - $172,584	368 Added 7.81%	5,077 $2.38 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $112,448 - $132,064	-362 Reduced 7.14%	4,709 $1.62 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $135,694 - $158,110	422 Added 9.08%	5,071 $1.86 Million
Q3 2022 Nov 16, 2022	BUY	$296.48 - $337.87 $17,195 - $19,596	58 Added 1.26%	4,649 $1.66 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $15,887 - $18,654	-57 Reduced 1.23%	4,591 $1.49 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $2,816 - $3,499	12 Added 0.26%	4,648 $1.33 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $53,064 - $65,853	236 Added 5.36%	4,636 $1.28 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $35,456 - $43,633	160 Added 3.77%	4,400 $1.02 Million
Q2 2021 Aug 02, 2021	BUY	$180.55 - $233.54 $25,096 - $32,462	139 Added 3.39%	4,240 $973,000
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $127,512 - $165,070	776 Added 23.34%	4,101 $766,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $7,305 - $9,667	56 Added 1.71%	3,325 $561,000
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $51,177 - $59,195	350 Added 11.99%	3,269 $484,000
Q2 2020 Aug 18, 2020	BUY	$136.42 - $164.18 $16,233 - $19,537	119 Added 4.25%	2,919 $479,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $2,976 - $3,683	-25 Reduced 0.88%	2,800 $388,000
Q4 2019 Jan 10, 2020	BUY	$106.92 - $132.43 $962 - $1,191	9 Added 0.32%	2,825 $371,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $9,611 - $10,454	90 Added 3.3%	2,816 $315,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $110 - $129	-1 Reduced 0.04%	2,726 $302,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $40,628 - $47,822	365 Added 15.45%	2,727 $352,000
Q4 2018 Jan 17, 2019	BUY	$105.9 - $118.64 $250,135 - $280,227	2,362 New	2,362 $273,000

Others Institutions Holding LLY

# of Institutions

4,031

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.

Account

Advisors Capital Management, LLC Eli Lilly & CO Transaction History